Our studies indicate that the targeting of SLC39A6 might be potential therapeutic strategy for blocking ESCC proliferation by restriction specific minerals, such as zinc, via knockdown of SLC39A6. Here, SLC39A6 is linked to esophageal squamous cell carcinoma.